4月14日 - ** 生物制药公司 Cara Therapeutics CARA.O 股价上涨 14.5% 至 5.61 美元
** Cara 表示 (link)，董事会已批准从 4 月 15 日起进行 1 对 3 的反向股票分割
** 卡拉公司于 12 月与私人控股的 Tvardi Therapeutics 公司达成合并协议
** 预计合并完成后，股票分割将以新名称 "Tvardi Therapeutics Inc "进行，股票代码为 "TVRD"。
** 合并完成后，合并后公司的流通股总数预计约为 940 万股
** 截至上一交易日收盘，CARA公司股价累计下跌14.2%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.